Effective August 1, 2025: Genetic Testing PLA Expansion
Date: 05/01/25
Effective August 1, 2025, prior authorization will be required for Ambetter from Superior HealthPlan members for additional genetic testing Proprietary Laboratory Analyses (PLA) codes that were evaluated and added to Evolent’s Genetic Testing Clinical Guidelines. There were no clinical criteria changes to policy as a result of this code update.
Prior authorization requests for members of all ages should be submitted to Evolent’s webpage, or by calling 1-800-642-7554 or faxing to 1-800-784-6864.
Ambetter ensures medical necessity review criteria is current and appropriate for members and the scope of services provided. The codes impacted by this change are:
PLA Code | Description | Criteria |
0340U | ONC PAN CANCER ANALYSIS MRD FROM PLASMA | Evolent’s Genetic Testing Clinical Guidelines that will be utilized for these services can be found on Evolent’s Genetic Testing webpage.
|
0422U | ONC PAN SOLID TUM ALYS DNA BMRK RSPSE ANTCA THER | |
0488U | OB FTL AG NIPT CFDNA SEQ ALYS DETCJ FTL PRESENCE | |
0532U | RARE DS RAPID WHL GEN AND MITOCHDRL DNA SEQ SNV SLV | |
0533U | RX METAB ADVRS RX RXN AND RSPSE GNOTYP 16 GENES | |
0534U | ONC PRST8 MIRNA SNP ALYS RT-PCR 32VRNT BUCC SWAB | |
0536U | RBC AG FETAL RHD PCR ALYS EXON 4 RHD GENE AND GAPDH | |
0538U | ONC SOLID TUM NGTS ALYS FFPE DNA ALYS 600 GENES | |
0539U | ONC SOLID TUMOR CFCTDNA 152 GEN NGS INTERROG SNV | |
0543U | ONC SOL TUM NGS DNA FFPE TISS 517GEN INTEROG SNV | |
0549U | ONC URTHL DNA QUAN MTHYLTD RT PCR TRNA-CYS SIM2 | |
0523U | ONC SOLID TUMOR DNA QUAL NGS SNV 22GEN FFPE TISS | |
0530U | ONC PAN-SOL TUM CTDNA PLSM NGS 77 GEN 8 FUJN MSI |
To review Evolent’s prior authorization requirements, please visit Evolent's webpage.
For questions or additional information, contact Ambetter’s Prior Authorization department at 1-877-687-1196.